ProCE Banner Activity

Current Evidence on Therapeutic Approaches to BCBM: HER2-Negative Disease

Slideset Download
Download this slideset for an expert-curated overview of the latest clinical data informing optimal management of HER2-negative breast cancer brain metastases, including a look at new strategies on the horizon.

Released: December 10, 2020

Expiration: December 09, 2021

No longer available for credit.

Share

Faculty

Ruth M. O’Regan

Ruth M. O’Regan, MD

Associate Professor, Hematology and Oncology, Medical Oncology
Director of Translational Breast Cancer Research
Winship Cancer Institute
Emory University
Atlanta, Georgia

Provided by

Provided by Clinical Care Options, LLC
ProCE Banner

Supporters

Supported by educational grants from

Genentech, a member of the Roche Group

Puma Biotechnology, Inc.

Faculty Disclosure

Primary Author

Ruth M. O’Regan, MD

Associate Professor, Hematology and Oncology, Medical Oncology
Director of Translational Breast Cancer Research
Winship Cancer Institute
Emory University
Atlanta, Georgia